118
Early biopsy with characteristic histologic findings helps the diag-
nosis. Treatment of choice for small, well-circumscribed lesions
is enucleation.
http://dx.doi.org/10.1016/j.ijom.2017.02.413We can save not only lives, but also quality of life:
submandibular gland-sparing neck dissection
K.C. Chen
∗
, T.Y. Wong, J.S. Huang, T.T. Huang
National Cheng Kung University Hospital, Chinese Taipei
Background:
Saliva is important to oral health and submandibu-
lar gland provide 70% of daily production. Neck dissection with
gland removal is the traditional guideline in oral squamous cell
carcinoma (OSCC) patients. Reduction of saliva would be noted
postoperatively and impairs quality of life (QoL) due to xerosto-
mia. Survival rate of OSCC reaches a plateau and what we can do
more is to improve QoL.
Objectives:
According to some published papers and our own
study. Almost no submandibular glands metastasis by pathology
even in positive level Ib neck. Our idea is that why we don’t try to
preserve submandibular gland since it seems to be safe to keep in
neck.
Methods:
Preserve gland in ipsilateral or contralateral pathologi-
cal N0 neck. Subjective test for function are saliva flow fromorifice
by digital pressure and patient’s sensation. Saliva scintigraphy
worked as objective test.
Findings and Conclusion:
From 2004 to 2016, total 58 cases
included 59 tumours and 63 necks and glands. Fail to complete
functional tests in seven glands finally due to recurrence or radio-
therapy. Four local recurrence and three neck recurrence in average
33 months follow-up. In 56 glands with tests, two cases without
saliva flow from orifice were observed and three cases felt mild
xerostomia. Saliva scintigraphy was done in 24 cases, seven cases
showed normal function, 13 cases showed mild xerostomia. Oth-
ers are moderate xerostomia. We conclude that our method not
only preserve function but also no increasing risk to recurrence.
In other words, we could save not only lives but also QoL.
http://dx.doi.org/10.1016/j.ijom.2017.02.414Clinical implication of discrepancy between overall survival
and disease-specific survival rate in oral cavity squamous cell
carcinoma
C.S. Cheng
∗
, Y.M. Chang
Department of Stomatology, Division of Oral and Maxillofacial
Surgery, Taichung Veterans General Hospital, Chinese Taipei
Generally, two types of survival estimations, overall survival (OS)
and disease-specific survival (DSS) rate, are commonly used to
measure clinical prognosis and explore predictive factors as well.
OS rate is commonly used by clinicians due to the patients survival
status can be easily obtained but without any information about
underlying causes of death. On the other hand, DSS rate is more
sophisticated that counts death caused by specific disease; other
causes of death were refereed as right-censored. Thus, it could be
easy to find the discrepancy (gap or disparity) between two survival
estimations. However, the most important argument is that this
discrepancy (gap or disparity) could be representing the possibility
to increase the bias (overestimation or/and underestimation).
The aim of this study was to investigate characteristics of this
discrepancy between two survival curves to explore the clinical
implications. We studied consecutive patients with oral cavity
squamous cell carcinoma (1985–2013). In our primarily result
showed, age of 60 years as a cut-off point to show discrepancy
occurred significantly that increased by aged patients. In case of
evaluation of outcomes by overall survival rate, it is significant
amount of non-cancer death as a competitive risk might cause
overestimation of mortality of elder patients. So we recommend
that disease-specific survival rate could be an adequate estimation
for elderly patients, especially over the age of 60 years.
http://dx.doi.org/10.1016/j.ijom.2017.02.415Induction chemotherapy with or without radical surgery for
advanced stage-IVb oral cancer: seven-year experience of
National Taiwan University Hospital
E.S.J. Cheng
School of Dentistry, National Taiwan University and
Department of Oral and Maxillofacial Surgery, National Taiwan
University Hospital, Taipei, Chinese Taipei
Background:
The strategy of clinical stage-IVb oral cancer is
quite challenging. Especially when it involves the infratemporal
region, the five-year survival rate is dismal and less than 20%.
Objectives:
The purpose of this study was to explore the effect of
induction chemotherapy (IC) and flexibility of proposed infratem-
poral resection method for advanced oral cancer.
Methods:
88 cases completed the full treatment protocol from
98 enrolled patients. 48 group one patients were administered
for two cycles of bevacizumab 100 mg/vial on day one, cisplatin
75 mg/m
2
on day one, fluorouracil 1000 mg/m
2
on day 1, 2 (APF)
followed by radical surgery and concurrent chemoradiotherapy
(CCRT), mainly based on internal carotid artery spared, partial
response (more than 30% tumour shrinkage), systemic considera-
tion or patient’s motivation. The IC regimen and CCRT were only
applied to 40 subjects of group two not eligible for surgery. We
proposed a surgical technique to undergo radical infratemporal
resection with coronal approach to basal skull. The primary end
point was overall survival (OS). Secondary end points comprised
flexibility of proposed surgical method, IC effect and complication
rate.
Findings:
Neither unexpected toxicities nor mortality was docu-
mented during the first two months. No difference of complication
rate was recorded. However, partial response of IC was favoured
by surgical group as 54%. Furthermore, five-year OS had signifi-
cantly shown longer for surgical group than the other (52% versus
22%,
P
< 0.01).
Conclusion:
The study demonstrated the IC combined with pro-
posed surgical technique could be employed for those advanced
stage-IVb oral cancer patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.416




